Unique genomic arrangements in an invasive serotype M23 strain of Streptococcus pyogenes identify genes that induce hypervirulence

Journal of Bacteriology

Volumn 196, Issue 23, 2014, Pages 4089-4102

  Bao, Yunjuan ^a,b   Liang, Zhong ^a   Booyjzsen, Claire ^a   Mayfield, Jeffrey A ^a   Li, Yang ^b   Lee, Shaun W ^a   Ploplis, Victoria A ^a   Song, Hui ^b   Castellino, Francis J ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b Tianjin Airport Economic Area   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; DEOXYRIBONUCLEASE; FIBRONECTIN BINDING PROTEIN; HYALURONIC ACID; M PROTEIN; STREPTOKINASE; STREPTOLYSIN O; VIRULENCE FACTOR;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; COMPARATIVE STUDY; EPITHELIUM CELL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC RECOMBINATION; GENOME; GENOMICS; GROUP A STREPTOCOCCAL INFECTION; HORIZONTAL GENE TRANSFER; IMMUNE EVASION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PSEUDOGENE; SEROTYPE; STREPTOCOCCUS PYOGENES; BACTERIAL GENOME; BACTERIUM ADHERENCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ORDER; GENETICS; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; PHYSIOLOGY; PROPHAGE; VIRULENCE;

BACTERIAL ADHESION; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; GENE ORDER; GENE TRANSFER, HORIZONTAL; GENOME, BACTERIAL; POLYMERASE CHAIN REACTION; PROPHAGES; PSEUDOGENES; RECOMBINATION, GENETIC; SEROGROUP; STREPTOCOCCUS PYOGENES; VIRULENCE; VIRULENCE FACTORS;

EID: 84910009577     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.02131-14     Document Type: Article

References (77)

1. Lancefield RC. 1928. The antigenic complex of Streptococcus haemolyticus. I. Demonstration of a type-specific substance in extracts of Streptococcus haemolyticus. J. Exp. Med. 47:91-103.
2. Carapetis JR, Steer AC, Mulholland EK, Weber M. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5:685-694. http://dx.doi.org/10.1016/S1473-3099(05)70267-X.
3. Schwartz B, Facklam RR, Breiman RF. 1990. Changing epidemiology of group A streptococcal infection in the USA. Lancet 336:1167-1171. http://dx.doi.org/10.1016/0140-6736(90)92777-F.
4. Smoot JC, Barbian KD, Van Gompel JJ, Smoot LM, Chaussee MS, Sylva GL, Sturdevant DE, Ricklefs SM, Porcella SF, Parkins LD, Beres SB, Campbell DS, Smith TM, Zhang Q, Kapur V, Daly JA, Veasy LG, Musser JM. 2002. Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc. Natl. Acad. Sci. U. S. A. 99:4668-4673. http://dx.doi.org/10.1073/pnas.062526099.
5. Sanderson-Smith M, De Oliveira DM, Guglielmini J, McMillan DJ, Vu T, Holien JK, Henningham A, Steer AC, Bessen DE, Dale JB, Curtis N, Beall BW, Walker MJ, Parker MW, Carapetis JR, Van Melderen L, Sriprakash KS, Smeesters PR, the M Protein Study Group. 5 May 2014. A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development. J. Infect. Dis. http://dx.doi.org/10.1093/infdis/jiu260.
6. Smeesters PR, McMillan DJ, Sriprakash KS. 2010. The streptococcal M protein: a highly versatile molecule. Trends Microbiol. 18:275-282. http://dx.doi.org/10.1016/j.tim.2010.02.007.
7. Fischetti VA. 1991. Streptococcal M protein. Sci. Am. 264:58-65. http://dx.doi.org/10.1038/scientificamerican0691-58.
8. Beall B, Facklam R, Thompson T. 1996. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J. Clin. Microbiol. 34:953-958.
9. Hollingshead SK, Readdy TL, Yung DL, Bessen DE. 1993. Structural heterogeneity of the emm gene cluster in group A streptococci. Mol. Microbiol. 8:707-717. http://dx.doi.org/10.1111/j.1365-2958.1993.tb01614.x.
10. Podbielski A. 1993. Three different types of organization of the vir regulon in group A streptococci. Mol. Gen. Genet. 237:287-300.
11. Bessen DE, Sotir CM, Readdy TL, Hollingshead SK. 1996. Genetic correlates of throat and skin isolates of group A streptococci. J. Infect. Dis. 173:896-900. http://dx.doi.org/10.1093/infdis/173.4.896.
12. Bessen DE, Izzo MW, Fiorentino TR, Caringal RM, Hollingshead SK, Beall B. 1999. Genetic linkage of exotoxin alleles and emm gene markers for tissue tropism in group A streptococci. J. Infect. Dis. 179:627-636. http://dx.doi.org/10.1086/314631.
13. Terao Y, Kawabata S, Kunitomo E, Murakami J, Nakagawa I, Hamada S. 2001. Fba, a novel fibronectin-binding protein from Streptococcus pyogenes, promotes bacterial entry into epithelial cells, and the fba gene is positively transcribed under the Mga regulator. Mol. Microbiol. 42:75-86. http://dx.doi.org/10.1046/j.1365-2958.2001.02579.x.
14. Ramachandran V, McArthur JD, Behm CE, Gutzeit C, Dowton M, Fagan PK, Towers R, Currie B, Sriprakash KS, Walker MJ. 2004. Two distinct genotypes of prtF2, encoding a fibronectin binding protein, and evolution of the gene family in Streptococcus pyogenes. J. Bacteriol. 186: 7601-7609. http://dx.doi.org/10.1128/JB.186.22.7601-7609.2004.
15. Liang Z, Zhang Y, Agrahari G, Chandrahas V, Glinton K, Donahue DL, Balsara RD, Ploplis VA, Castellino FJ. 2013. A natural inactivating mutation in the CovS component of the CovRS regulatory operon in a pattern D streptococcal pyogenes strain influences virulence-associated genes. J. Biol. Chem. 288:6561-6573. http://dx.doi.org/10.1074/jbc.M112.442657.
16. Molinari G, Rohde M, Guzmán CA, Chhatwal GS. 2000. Two distinct pathways for the invasion of Streptococcus pyogenes in non-phagocytic cells. Cell. Microbiol. 2:145-154. http://dx.doi.org/10.1046/j.1462-5822.2000.00040.x.
17. Bessen D, Jones KF, Fischetti VA. 1989. Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. J. Exp. Med. 169:269-283. http://dx.doi.org/10.1084/jem.169.1.269.
18. Guzman CA, Talay SR, Molinari G, Medina E, Chhatwal GS. 1999. Protective immune response against Streptococcus pyogenes in mice after intranasal vaccination with the fibronectin-binding protein SfbI. J. Infect. Dis. 179:901-906. http://dx.doi.org/10.1086/314655.
19. Jeng A, Sakota V, Li Z, Datta V, Beall B, Nizet V. 2003. Molecular genetic analysis of a group A Streptococcus operon encoding serum opacity factor and a novel fibronectin-binding protein, SfbX. J. Bacteriol. 185: 1208-1217. http://dx.doi.org/10.1128/JB.185.4.1208-1217.2003.
20. Courtney HS, Li Y, Dale JB, Hasty DL. 1994. Cloning, sequencing, and expression of a fibronectin/fibrinogen-binding protein from group A streptococci. Infect. Immun. 62:3937-3946.
21. Courtney HS, Dale JB, Hasty DI. 1996. Differential effects of the streptococcal fibronectin-binding protein, FBP54, on adhesion of group A streptococci to human buccal cells and HEp-2 tissue culture cells. Infect. Immun. 64:2415-2419.
22. Perez-Casal J, Caparon MG, Scott JR. 1991. Mry, a trans-acting positive regulator of theMprotein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems. J. Bacteriol. 173:2617-2624.
23. Hondorp ER, McIver KS. 2007. The Mga virulence regulon: infection where the grass is greener. Mol. Microbiol. 66:1056-1065. http://dx.doi.org/10.1111/j.1365-2958.2007.06006.x.
24. Kreikemeyer B, KS McIver, Podbielski A. 2003. Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions. Trends Microbiol. 11:224-232. http://dx.doi.org/10.1016/S0966-842X(03)00098-2.
25. Simpson WJ, LaPenta D, Chen C, Cleary PP. 1990. Coregulation of type 12 M protein and streptococcal C5a peptidase genes in group A streptococci: evidence for a virulence regulon controlled by the virR locus. J. Bacteriol. 172:696-700.
26. Stenberg L, O'Toole P, Lindahl G. 1992. Many group A streptococcal strains express two different immunoglobulin-binding proteins, encoded by closely linked genes: characterization of the proteins expressed by four strains of different M-type. Mol. Microbiol. 6:1185-1194. http://dx.doi.org/10.1111/j.1365-2958.1992.tb01557.x.
27. Almengor AC, Walters MS, McIver KS. 2006. Mga is sufficient to activate transcription in vitro of sof-sfbX and other Mga-regulated virulence genes in the group A streptococcus. J. Bacteriol. 188:2038-2047. http://dx.doi.org/10.1128/JB.188.6.2038-2047.2006.
28. Ferretti JJ, McShan WM, Ajdic D, Savic DJ, Savic G, Lyon K, Primeaux C, Sezate S, Suvorov AN, Kenton S, Lai HS, Lin SP, Qian Y, Jia HG, Najar FZ, Ren Q, Zhu H, Song L, White J, Yuan X, Clifton SW, Roe BA, McLaughlin R. 2001. Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc. Natl. Acad. Sci. U. S. A. 98:4658-4663. http://dx.doi.org/10.1073/pnas.071559398.
29. Okamoto H, Minami M, Shoin S, Koshimura S, Shimizu R. 1966. Experimental anticancer studies. XXXI. On the streptococcal preparation having potent anticancer activity. Jpn. J. Exp. Med. 36:175-186.
30. Delcher AL, Bratke KA, Powers EC, Salzberg SL. 2007. Identifying bacterial genes and endosymbiont DNA with Glimmer. Bioinformatics 23:673-679. http://dx.doi.org/10.1093/bioinformatics/btm009.
31. Lagesen K, Hallin P, Rodland EA, Staerfeldt HH, Rognes T, Ussery DW. 2007. RNAmmer: consistent and rapid annotation of ribosomal RNA genes. Nucleic Acids Res. 35:3100-3108. http://dx.doi.org/10.1093/nar/gkm160.
32. Aziz RK, Kotb M. 2008. Rise and persistence of global M1T1 clone of Streptococcus pyogenes. Emerg. Infect. Dis. 14:1511-1517. http://dx.doi.org/10.3201/eid1410.071660.
33. Tatusova T, Ciufo S, Fedorov B, O'Neill K, Tolstoy I. 2014. RefSeq microbial genomes database: new representation and annotation strategy. Nucleic Acids Res. 42:D553-D559. http://dx.doi.org/10.1093/nar/gkt1274.
34. Alikhan NF, Petty NK, Ben Zakour NL, Beatson SA. 2011. BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genomics 12:402. http://dx.doi.org/10.1186/1471-2164-12-402.
35. Carver TJ, Rutherford KM, Berriman M, Rajandream MA, Barrell BG, Parkhill J. 2005. ACT: the Artemis comparison tool. Bioinformatics 21: 3422-3423. http://dx.doi.org/10.1093/bioinformatics/bti553.
36. McGregor KF, Spratt BG, Kalia A, Bennett A, Bilek N, Beall B, Bessen DE. 2004. Multilocus sequence typing of Streptococcus pyogenes representing most known emm types and distinctions among subpopulation genetic structures. J. Bacteriol. 186:4285-4294. http://dx.doi.org/10.1128/JB.186.13.4285-4294.2004.
37. Huson DH, Bryant D. 2006. Application of phylogenetic networks in evolutionary studies. Mol. Biol. Evol. 23:254-267. http://dx.doi.org/10.1093/molbev/msj030.
38. Okamoto H, Koshimura S. November 1969. Treating method of Streptococcus hemolyticus and preparation containing the said microorganism. US patent 3,477,914.
39. Sotomura M, Iwamoto S, Sawada T, Inoue S, Suzuki A, Ikeda Y. May. 1982. Method for the treatment of cells of Streptococcus pyogenes. US patent 4,328,218.
40. Okamoto H, Shoin S, Minami M, Koshimura S, Shimizu R. 1966. Experimental anticancer studies. XXX. Factors influencing the streptolysin S-forming ability of streptococci having anticancer activity. Jpn. J. Exp. Med. 36:161-174.
41. Hong K. 2000. Characterization of group A streptococcal strains Sv and Su: determination of emm gene typing and presence of small vir regulon. Res. Microbiol. 151:29-36. http://dx.doi.org/10.1016/S0923-2508(00)00130-3.
42. Scott J, Thompson-Mayberry P, Lahmamsi S, King CJ, McShan WM. 2008. Phage-associated mutator phenotype in group A streptococcus. J. Bacteriol. 190:6290-6301. http://dx.doi.org/10.1128/JB.01569-07.
43. Botstein D. 1980. A theory of modular evolution for bacteriophages. Ann. N. Y. Acad. Sci. 354:484-490. http://dx.doi.org/10.1111/j.1749-6632.1980.tb27987.x.
44. McShan WM, Ferretti JJ. 1997. Genetic diversity in temperate bacteriophages of Streptococcus pyogenes: identification of a second attachment site for phages carrying the erythrogenic toxin A gene. J. Bacteriol. 179: 6509-6511.
45. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P. 2007. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315:1709-1712. http://dx.doi.org/10.1126/science.1138140.
46. Marraffini LA, Sontheimer EJ. 2008. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 322:1843-1845. http://dx.doi.org/10.1126/science.1165771.
47. Brouns SJ, Jore MM, Lundgren M, Westra ER, Slijkhuis RJ, Snijders AP, Dickman MJ, Makarova KS, Koonin EV, van der Oost J. 2008. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321: 960-964. http://dx.doi.org/10.1126/science.1159689.
48. Nozawa T, Furukawa N, Aikawa C, Watanabe T, Haobam B, Kurokawa K, Maruyama F, Nakagawa I. 2011. CRISPR inhibition of prophage acquisition in Streptococcus pyogenes. PLoS One 6:e19543. http://dx.doi.org/10.1371/journal.pone.0019543.
49. Duggin IG, Dubarry N, Bell SD. 2011. Replication termination and chromosome dimer resolution in the archaeon Sulfolobus solfataricus. EMBO J. 30:145-153. http://dx.doi.org/10.1038/emboj.2010.301.
50. Nakagawa I, Kurokawa K, Yamashita A, Nakata M, Tomiyasu Y, Okahashi N, Kawabata S, Yamazaki K, Shiba T, Yasunaga T, Hayashi H, Hattori M, Hamada S. 2003. Genome sequence of an M3 strain of Streptococcus pyogenes reveals a large-scale genomic rearrangement in invasive strains and new insights into phage evolution. Genome Res. 13: 1042-1055. http://dx.doi.org/10.1101/gr.1096703.
51. Esnault E, Valens M, Espeli O, Boccard F. 2007. Chromosome structuring limits genome plasticity in Escherichia coli. PLoS Genet. 3:e226. http://dx.doi.org/10.1371/journal.pgen.0030226.
52. Matthews TD, Maloy S. 2010. Fitness effects of replichore imbalance in Salmonella enterica. J. Bacteriol. 192:6086-6088. http://dx.doi.org/10.1128/JB.00649-10.
53. Musser JM, Nelson K, Selander RK, Gerlach D, Huang JC, Kapur V, Kanjilal S. 1993. Temporal variation in bacterial disease frequency: molecular population genetic analysis of scarlet fever epidemics in Ottawa and in eastern Germany. J. Infect. Dis. 167:759-762. http://dx.doi.org/10.1093/infdis/167.3.759.
54. Aziz RK, Edwards RA, Taylor WW, Low DE, McGeer A, Kotb M. 2005. Mosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes. J. Bacteriol. 187:3311-3318. http://dx.doi.org/10.1128/JB.187.10.3311-3318.2005.
55. Hanski E, Caparon M. 1992. Protein F, a fibronectin-binding protein, is an adhesin of the group A streptococcus Streptococcus pyogenes. Proc. Natl. Acad. Sci. U. S. A. 89:6172-6176. http://dx.doi.org/10.1073/pnas.89.13.6172.
56. Mayfield JA, Liang Z, Agrahari G, Lee SW, Donahue DL, Ploplis VA, Castellino FJ. 2014. Mutations in the control of virulence sensor gene from Streptococcus pyogenes after infection in mice lead to clonal bacterial variants with altered gene regulatory activity and virulence. PLoS One 9:e100698. http://dx.doi.org/10.1371/journal.pone.0100698.
57. Anbalagan S, Dmitriev A, McShan WM, Dunman PM, Chaussee MS. 2012. Growth phase-dependent modulation of Rgg binding specificity in Streptococcus pyogenes. J. Bacteriol. 194:3961-3971. http://dx.doi.org/10.1128/JB.06709-11.
58. Maamary PG, Ben Zakour NL, Cole JN, Hollands A, Aziz RK, Barnett TC, Cork AJ, Henningham A, Sanderson-Smith M, McArthur JD, Venturini C, Gillen CM, Kirk JK, Johnson DR, Taylor WL, Kaplan EL, Kotb M, Nizet V, Beatson SA, Walker MJ. 2012. Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clone. FASEB J. 26:4675-4684. http://dx.doi.org/10.1096/fj.12-212142.
59. Wieles B, OttenhoffTH, Steenwijk TM, Franken KL, de Vries RR, Langermans JA. 1997. Increased intracellular survival of Mycobacterium smegmatis containing the Mycobacterium leprae thioredoxinthioredoxin reductase gene. Infect. Immun. 65:2537-2541.
60. Cole JN, Barnett TC, Nizet V, Walker MJ. 2011. Molecular insight into invasive group A streptococcal disease. Nat. Rev. Microbiol. 9:724-736. http://dx.doi.org/10.1038/nrmicro2648.
61. Maamary PG, Sanderson-Smith ML, Aziz RK, Hollands A, Cole JN, McKay FC, McArthur JD, Kirk JK, Cork AJ, Keefe RJ, Kansal RG, Sun H, Taylor WL, Chhatwal GS, Ginsburg D, Nizet V, Kotb M, Walker MJ. 2010. Parameters governing invasive disease propensity of non-M1 serotype group A streptococci. J. Innate Immun. 2:596-606. http://dx.doi.org/10.1159/000317640.
62. Cole JN, McArthur JD, McKay FC, Sanderson-Smith ML, Cork AJ, Ranson M, Rohde M, Itzek A, Sun H, Ginsburg D, Kotb M, Nizet V, Chhatwal GS, Walker MJ. 2006. Trigger for group A streptococcal M1T1 invasive disease. FASEB J. 20:1745-1747. http://dx.doi.org/10.1096/fj.06-5804fje.
63. Miyoshi-Akiyama T, Ikebe T, Watanabe H, Uchiyama T, Kirikae T, Kawamura Y. 2006. Use of DNA arrays to identify a mutation in the negative regulator, csrR, responsible for the high virulence of a naturally occurring type M3 group A streptococcus clinical isolate. J. Infect. Dis. 193:1677-1684. http://dx.doi.org/10.1086/504263.
64. Garcia AF, Abe LM, Erdem G, Cortez CL, Kurahara D, Yamaga K. 2010. An insert in the covS gene distinguishes a pharyngeal and a blood isolate of Streptococcus pyogenes found in the same individual. Microbiology 156: 3085-3095. http://dx.doi.org/10.1099/mic.0.042614-0.
65. Tsai PJ, Kuo CF, Lin KY, Lin YS, Lei HY, Chen FF, Wang JR, Wu JJ. 1998. Effect of group A streptococcal cysteine protease on invasion of epithelial cells. Infect. Immun. 66:1460-1466.
66. Wei L, Pandiripally V, Gregory E, Clymer M, Cue D. 2005. Impact of the SpeB protease on binding of the complement regulatory proteins factorH and factor H-like protein 1 by Streptococcus pyogenes. Infect. Immun. 73:2040-2050. http://dx.doi.org/10.1128/IAI.73.4.2040-2050.2005.
67. Agrahari G, Liang Z, Mayfield JA, Balsara RD, Ploplis VA, Castellino FJ. 2013. Complement-mediated opsonization of invasive group A Streptococcus pyogenes strain AP53 is regulated by the bacterial twocomponent cluster of virulence responder/sensor (CovRS) system. J. Biol. Chem. 288:27494-27504. http://dx.doi.org/10.1074/jbc.M113.494864.
68. Kapur V, Topouzis S, Majesky MW, Li LL, Hamrick MR, Hamill RJ, Patti JM, Musser JM. 1993. A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb. Pathog. 15:327-346. http://dx.doi.org/10.1006/mpat.1993.1083.
69. Kapur V, Majesky MW, Li LL, Black RA, Musser JM. 1993. Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc. Natl. Acad. Sci. U. S. A. 90:7676-7680. http://dx.doi.org/10.1073/pnas.90.16.7676.
70. Collin M, Olsen A. 2001. Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect. Immun. 69:7187-7189. http://dx.doi.org/10.1128/IAI.69.11.7187-7189.2001.
71. Honda-Ogawa M, Ogawa T, Terao Y, Sumitomo T, Nakata M, Ikebe K, Maeda Y, Kawabata S. 2013. Cysteine proteinase from Streptococcus pyogenes enables evasion of innate immunity via degradation of complement factors. J. Biol. Chem. 288:15854-15864. http://dx.doi.org/10.1074/jbc.M113.469106.
72. Sumitomo T, Nakata M, Higashino M, Terao Y, Kawabata S. 2013. Group A streptococcal cysteine protease cleaves epithelial junctions and contributes to bacterial translocation. J. Biol. Chem. 288:13317-13324. http://dx.doi.org/10.1074/jbc.M113.459875.
73. Chaussee MS, Ajdic D, Ferretti JJ. 1999. The rgg gene of Streptococcus pyogenes NZ131 positively influences extracellular SPE B production. Infect. Immun. 67:1715-1722.
74. Cole JN, Pence MA, von Köckritz-Blickwede M, Hollands A, Gallo RL, Walker MJ, Nizet V. 2010. M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A streptococcus. mBio 1(4):e00191-10. http://dx.doi.org/10.1128/mBio.00191-10.
75. Zhang Y, Liang Z, Hsueh HT, Ploplis VA, Castellino FJ. 2012. Characterization of streptokinases from group A streptococci reveals a strong functional relationship that supports the coinheritance of plasminogenbinding M-protein and cluster 2b streptokinase. J. Biol. Chem. 287: 42093-42103. http://dx.doi.org/10.1074/jbc.M112.417808.
76. Zhang Y, Liang Z, Glinton K, Ploplis VA, Castellino FJ. 2013. Functional differences between Streptococcus pyogenes cluster 1 and cluster 2b streptokinases are determined by their β-domains. FEBS Lett. 587:1304-1309. http://dx.doi.org/10.1016/j.febslet.2013.02.033.
77. Zhang Y, Mayfield J, Ploplis VA, Castellino FJ. 2014. The β-domain of cluster 2b streptokinase is a major determinant for the regulation of its plasminogen activation activity by cellular plasminogen receptors. Biochem. Biophys. Res. Commun. 444:595-598. http://dx.doi.org/10.1016/j.bbrc.2014.01.109.